title: Author reply: To PMID 25012934.
authors.affiliation: Retina Consultants of Houston, Houston, Texas. Electronic address: dmbmd@houstonretina.com.
authors.forename: David M
authors.initials: DM
authors.lastname: Brown
authors.affiliation: Service d' ophtalmologie, Hôpital Pellegrin - CHU de Bordeaux, Bordeaux, France.
authors.forename: Jean-Francois
authors.initials: JF
authors.lastname: Korobelnik
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D003930:Diabetic Retinopathy / Q000188:drug therapy* / Q000601:surgery*; D005260:Female; D006801:Humans; D017075:Laser Coagulation; D008269:Macular Edema / Q000188:drug therapy* / Q000601:surgery*; D008297:Male; D040262:Receptors, Vascular Endothelial Growth Factor / Q000627:therapeutic use*; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*
chemical_list: D020533:Angiogenesis Inhibitors; D011993:Recombinant Fusion Proteins; D040262:Receptors, Vascular Endothelial Growth Factor